Atreo.io logo — Atreo helps clinical teams to modernize the RTSM | IRT exper...

Atreo.io

Atreo helps clinical teams to modernize the RTSM | IRT experience at unmatched agility and simplicity

Founded 2021 United States San Francisco, United States 40 employees Pre-Seed Total: $5.75M Health Care, Information Technology

General Information

Company Name Atreo.io
Founded Year 2021
Location United States San Francisco, United States
Employees 40
Industries Health Care, Information Technology
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Atreo.io. To contact Atreo.io, visit atreo.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Atreo.io

Atreo.io is a health care and information technology startup founded in 2021 that aims to modernize the experience of clinical teams with its novel RTSM platform. The company is focused on addressing the pain points of legacy RTSM deployments by offering advantages in speed, rapid prototyping, quality, and agility. Atreo.io has received a $4.00M Pre Seed Round investment on 06 June 2022 from notable investors including Jon Dole, Stewart Butterfield, and Cal Henderson. The company's revolutionary System Design Experience allows for RTSM builds within 1-2 weeks, including system specifications, and offers unmatched testing coverage and time savings through modern architecture and processes. With a focus on time better spent, Atreo.io seeks to redefine the expectations of clinical teams through its innovative RTSM platform.

Taxonomy: RTSM, Clinical Trials, Clinical Supplies, Biotechs, Pharma, CROs, System Design Experience, Rapid Prototyping, Agility, Modern Testing Practices, Quality Quantification, System Agility, RTSM Build, Clinical Team Modernization, Client Experience

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $4.00M 3
Jon Dole, Stewart Butterfield +1
06 Jun 2022
Pre Seed Round $1.75M -
07 May 2021

Atreo.io Alternatives & Competitors

Atreo.io vs
Cenduit
Cenduit United States

Accelerating clinical trials through: Quality, Flexibility & Expertise.

179 employees
Biotechnology, Health Care
Atreo.io vs

Powering clinical trials across the globe with data driven forecasting and supply chain efficiency t...

Venture round
12 employees
Biotechnology, Health Care
Atreo.io vs
Complion
Complion United States

We deliver industry-leading investigator regulatory solutions for clinical trial sites, sponsors, an...

Private Equity
10 employees
Analytics, Health Care

FAQ About Atreo.io

Atreo helps clinical teams to modernize the RTSM | IRT experience at unmatched agility and simplicity
Atreo.io was founded in 2021.
Atreo.io is headquartered in San Francisco, United States.
Atreo.io operates in Health Care and Information Technology. Its work centres on RTSM, Clinical Trials, Clinical Supplies and Biotechs.
Atreo.io has approximately 40 employees.
Atreo.io has completed 2 funding rounds, raising a total of $5.75M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Atreo.io include Cenduit, Innovative Supply Solutions, Complion, Clinical ink, Vibrent Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Atreo.io and Cenduit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Atreo.io, https://bouncewatch.com/company/atreoio, updated 6 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes